Literature DB >> 17434289

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Chang-En Yu1, Howard Seltman, Elaine R Peskind, Nichole Galloway, Peter X Zhou, Elisabeth Rosenthal, Ellen M Wijsman, Debby W Tsuang, Bernie Devlin, Gerard D Schellenberg.   

Abstract

The epsilon(4) allele of APOE confers a two- to fourfold increased risk for late-onset Alzheimer's disease (LOAD), but LOAD pathology does not all fit neatly around APOE. It is conceivable that genetic variation proximate to APOE contributes to LOAD risk. Therefore, we investigated the degree of linkage disequilibrium (LD) for a comprehensive set of 50 SNPs in and surrounding APOE using a substantial Caucasian sample of 1100 chromosomes. SNPs in APOE were further molecularly haplotyped to determine their phases. One set of SNPs in TOMM40, roughly 15 kb upstream of APOE, showed intriguing LD with the epsilon(4) allele and was strongly associated with the risk for developing LOAD. However, when all the SNPs were entered into a logit model, only the effect of APOE epsilon(4) remained significant. These observations diminish the possibility that loci in the TOMM40 gene may have a major effect on the risk for LOAD in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434289      PMCID: PMC1978251          DOI: 10.1016/j.ygeno.2007.02.002

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  50 in total

1.  Characterization of multilocus linkage disequilibrium.

Authors:  Alessandro Rinaldo; Silviu-Alin Bacanu; B Devlin; Vibhor Sonpar; Larry Wasserman; Kathryn Roeder
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

2.  Neuronal specific regulatory elements in apolipoprotein E gene proximal promoter.

Authors:  María C Ramos; Salomón Matías; María J Artiga; Julio Pozueta; Isabel Sastre; Fernando Valdivieso; María J Bullido
Journal:  Neuroreport       Date:  2005-06-21       Impact factor: 1.837

3.  Accounting for linkage disequilibrium among markers in linkage analysis: impact of haplotype frequency estimation and molecular haplotypes for a gene in a candidate region for Alzheimer's disease.

Authors:  Weiva Sieh; Chang-En Yu; Thomas D Bird; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Hum Hered       Date:  2007-01-11       Impact factor: 0.444

4.  Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.

Authors:  S M Fullerton; A G Clark; K M Weiss; D A Nickerson; S L Taylor; J H Stengârd; V Salomaa; E Vartiainen; M Perola; E Boerwinkle; C F Sing
Journal:  Am J Hum Genet       Date:  2000-09-13       Impact factor: 11.025

5.  Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue.

Authors:  S J Shih; C Allan; S Grehan; E Tse; C Moran; J M Taylor
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

6.  Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.

Authors:  R A Sweet; B Devlin; B G Pollock; D L Sukonick; K B Kastango; S-A Bacanu; K V Chowdari; S T DeKosky; R E Ferrell
Journal:  Mol Psychiatry       Date:  2005-11       Impact factor: 15.992

7.  Dissection of the mitochondrial import and assembly pathway for human Tom40.

Authors:  Adam D Humphries; Illo C Streimann; Diana Stojanovski; Amelia J Johnston; Masato Yano; Nicholas J Hoogenraad; Michael T Ryan
Journal:  J Biol Chem       Date:  2005-01-10       Impact factor: 5.157

8.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.

Authors:  Kristin K Nicodemus; Judith E Stenger; Donald E Schmechel; Kathleen A Welsh-Bohmer; Ann M Saunders; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-09-29       Impact factor: 2.660

9.  Tree scanning: a method for using haplotype trees in phenotype/genotype association studies.

Authors:  Alan R Templeton; Taylor Maxwell; David Posada; Jari H Stengård; Eric Boerwinkle; Charles F Sing
Journal:  Genetics       Date:  2004-09-15       Impact factor: 4.562

10.  Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism.

Authors:  Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

View more
  81 in total

1.  A comprehensive genetic association study of Alzheimer disease in African Americans.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; Jacki Buros; Robert C Green; Rodney C P Go; Patrick Griffith; Thomas O Obisesan; Rhonna Shatz; Amy Borenstein; L Adrienne Cupples; Kathryn L Lunetta; M Daniele Fallin; Clinton T Baldwin; Lindsay A Farrer
Journal:  Arch Neurol       Date:  2011-12

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Identifying disease polymorphisms from case-control genetic association data.

Authors:  L Park
Journal:  Genetica       Date:  2010-10-14       Impact factor: 1.082

4.  Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.

Authors:  Nathan A Bihlmeyer; Emily Merrill; Yann Lambert; Gyan P Srivastava; Timothy W Clark; Bradley T Hyman; Sudeshna Das
Journal:  Alzheimers Dement       Date:  2019-03-29       Impact factor: 21.566

5.  Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data.

Authors:  Richard Sherva; Clinton T Baldwin; Rivka Inzelberg; Badri Vardarajan; L Adrienne Cupples; Kathryn Lunetta; Abdalla Bowirrat; Adam Naj; Margaret Pericak-Vance; Robert P Friedland; Lindsay A Farrer
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  On Jim Watson's APOE status: genetic information is hard to hide.

Authors:  Dale R Nyholt; Chang-En Yu; Peter M Visscher
Journal:  Eur J Hum Genet       Date:  2008-10-22       Impact factor: 4.246

Review 7.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

8.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

Authors:  Carlos Cruchaga; Petra Nowotny; John S K Kauwe; Perry G Ridge; Kevin Mayo; Sarah Bertelsen; Anthony Hinrichs; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Arch Neurol       Date:  2011-08

Review 9.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

10.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.